Back to Archived Journals » Transplant Research and Risk Management » Volume 2
Transplant Research and Risk Management ceased publishing in April 2025. All articles that have been published in Transplant Research and Risk Management will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Transplant Research and Risk Management
- View all (91)
- Volume 16, 2024 (2)
- Volume 15, 2023 (1)
- Volume 14, 2022 (6)
- Volume 13, 2021 (3)
- Volume 12, 2020 (5)
- Volume 11, 2019 (8)
- Volume 10, 2018 (1)
- Volume 9, 2017 (7)
- Volume 8, 2016 (5)
- Volume 7, 2015 (8)
- Volume 6, 2014 (12)
- Volume 5 , 2013 (3)
- Volume 4, 2012 (5)
- Volume 3, 2011 (10)
- Volume 2, 2010 (13)
- Volume 1, 2009 (2)
Archive: Volume 2, 2010
Ethical issues in kidney transplantation – reflections from Nigeria
Joseph Olusesan Fadare, Babatunde L Salako
Transplant Research and Risk Management 2010, 2:87-91
Published Date: 19 November 2010
Delayed hyperacute rejection in a patient who developed clostridium difficile infection after ABO-incompatible kidney transplantation
Gerald S Lipshutz, Elaine F Reed, Phuong-Chi Pham, et al
Transplant Research and Risk Management 2010, 2:81-85
Published Date: 8 November 2010
Assessing the safety and quality of ward-based renal transplant biopsies
Kenneth Wu, Bindhu Musunuru, Chera Arunachalam, et al
Transplant Research and Risk Management 2010, 2:77-79
Published Date: 7 October 2010
Eleven years of management of children with intestinal failure and not candidates for intestinal transplantation
MI Spagnuolo, MP Cicalese, E Bruzzese, et al.
Transplant Research and Risk Management 2010, 2:71-75
Published Date: 1 September 2010
Role of tacrolimus prolonged release in the prevention of allograft rejection
Peter Abrams, Abhinav Humar, Henkie P Tan
Transplant Research and Risk Management 2010, 2:65-70
Published Date: 9 August 2010
Knowledge and level of awareness of renal transplantation among medical students in Nigeria
Augustine O Takure, Sylvester O Alikah, Vincent C Onuora
Transplant Research and Risk Management 2010, 2:59-64
Published Date: 22 July 2010
Clinical use of plerixafor in combination with granulocyte-colony stimulating factor in hematopoietic stem cell transplantation
Cedar J Fowler, Richard T Maziarz
Transplant Research and Risk Management 2010, 2:47-58
Published Date: 11 May 2010
Liver transplantation in Egypt from West to East
Galal H El-Gazzaz, Azza H El-Elemi
Transplant Research and Risk Management 2010, 2:41-46
Published Date: 7 April 2010
Valganciclovir for the prophylaxis and treatment of cytomegalovirus infection in solid organ transplantation
Erin Wade Ticehurst, Jennifer Trofe-Clark, Emily Blumberg, et al
Transplant Research and Risk Management 2010, 2:29-39
Published Date: 30 March 2010
Moving towards implementation of a clinical ethics consultation program in Egyptian liver transplant units
A H El-Elemi, G H El-Gazzaz
Transplant Research and Risk Management 2010, 2:23-27
Published Date: 16 March 2010
Low antigenicity of hematopoietic progenitor cells derived from human ES cells
Eun-Mi Kim, Nicholas Zavazava
Transplant Research and Risk Management 2010, 2:15-22
Published Date: 3 February 2010
Critical appraisal on the use of everolimus in renal transplantation as an immunosuppressant to prevent organ transplant rejection
Fernando Giron, Yenny Baez
Transplant Research and Risk Management 2010, 2:11-14
Published Date: 21 January 2010
Optimizing use of basiliximab in liver transplantation
Carlo B Ramirez, Adam Bozdin, Adam Frank, et al
Transplant Research and Risk Management 2010, 2:1-10
Published Date: 6 January 2010